This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Chan, V. W. S. Articles by Kaszas, Z. Search for Related Content PubMed PubMed Citation Articles by Chan, V. W. S. Articles by Kaszas, Z.

---

REGIONAL ANESTHESIA AND PAIN MEDICINE

Determining Minimum Effective Anesthetic Concentration of Hyperbaric Bupivacaine for Spinal Anesthesia

Department of Anesthesia, University of Toronto, The Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada

Address correspondence and reprint requests to Vincent W. S. Chan, MD, Department of Anesthesia, The Toronto Western Hospital, University Health Network, 339 Bathurst St., Toronto, Ontario, Canada M5T 2S8.

We determined the minimum effective anesthetic concentration (MEAC) of bupivacaine for spinal anesthesia, defined as the median effective concentration at which a spinal anesthetic produces surgically equivalent anesthesia within 20 min of administration in 50% of human subjects. Two doses of spinal bupivacaine (7.5 mg and 10 mg) were administered to 45 volunteers (19–39 yr) in a randomized, double-blinded fashion. Hyperbaric bupivacaine solutions of 0.1% to 0.75% containing 8.25% dextrose were administered intrathecally and MEAC established by using the Dixon’s up-and-down method. Complete anesthesia was defined as: 1) pinprick anesthesia at or higher than T12; 2) anesthesia to transcutaneous tetanic electric stimulation (50 Hz at 60 mA for 5 s) in the knees; and 3) complete leg paralysis, all occurring in both lower extremities within 20 min of intrathecal injection. We found that the MEAC of spinal bupivacaine was 0.43% (95% confidence interval 0.24–0.62) when 10 mg was administered. At this dose, a concentration as low as 0.1% could provide complete anesthesia, but consistent blockade was obtained only with the 0.7% solution. The 7.5-mg dose failed to provide complete anesthesia consistently, even in the presence of 0.75% (maximum). The current commercially available 0.75% concentration of hyperbaric bupivacaine seems to be clinically optimal when 10 mg is used if complete bilateral lower extremity blockade is desired.

Implications: The value of the minimum effective anesthetic concentration for hyperbaric spinal bupivacaine is dose-dependent. Complete anesthesia can be achieved with smaller concentrations when the dose of spinal anesthetic is increased. The current commercially available 0.75% concentration of hyperbaric bupivacaine seems to be clinically optimal when 10 mg is used if complete bilateral lower extremity blockade is desired.

This article has been cited by other articles:

				M. Taboada, J. Rodriguez, C. Valino, J. Carceller, B. Bascuas, J. Oliveira, J. Alvarez, F. Gude, and P. G. Atanassoff What Is the Minimum Effective Volume of Local Anesthetic Required for Sciatic Nerve Blockade? A Prospective, Randomized Comparison Between a Popliteal and a Subgluteal Approach Anesth. Analg., February 1, 2006; 102(2): 593 - 597. [Abstract] [Full Text] [PDF]